The counterfeiting of medicines is so prevalent yet totally unaddressed and therefore legal in international criminal law. A counterfeit medicine treaty should be drafted under the auspices of the World Health Organization.

With the Supreme Court taking up Arizona’s “show me your papers” immigration law, we’re once again thrust into a useful debate over the role of the government and the obligations of the citizen — and non-citizen. Rather than come at it from the usual angle, I thought I’d try something...

DPRK involvement in illicit activities, far from being an aberration, is instead part and parcel of its basic approach to diplomacy and economic policy.

India is a center for drug counterfeiting, a deadly business that is spreading to the United States and Europe.

Illegally copying a trademark is an important indicator of counterfeiting, although not necessarily of substandard drug quality.

The intent behind a proposed treaty to criminalize the manufacture and trade in counterfeited drugs is good, but only a treaty initiated by the World Health Organization will suffice.

Every day patients receive treatments that do not work properly. For many this means no relief from symptoms, but for some death is the result. Yet concerted action against such products is limited. Before we can discuss why that's the case, I will attempt to explain what kind of products don’t work, and what we should call them.

“What happens next?” is not really the question we should be asking. More important is to ask what the United States wants to happen next, and what it can do to bring about that outcome.